Physician Payment Disclosure Physician Payment Sunshine: DC Transparency Report, State Transparency Law… Thomas Sullivan Apr 4, 2013 0 ScienceDaily recently reported physician and hospital payments from pharmaceutical companies for the District of Columbia in 2011.…
Editorials Physician Payment Sunshine: ProPublica Database Leads with Disparaging… Thomas Sullivan Apr 3, 2013 0 Doctor collaborates with industry to conduct lifesaving, breakthrough research.” “Doctor educates colleagues about safety and…
Conflict of Interest OIG Special Fraud Alert – Physician Owned Distributors Thomas Sullivan Apr 2, 2013 0 OIG recently published a Special Fraud Alert on physician-owned entities that derive revenue from selling, or arranging for the…
CME Global Education Group Survey: 98% Credit CME as Helpful in Improving… Thomas Sullivan Apr 1, 2013 0 A recent survey developed by Global Education Group and Medical Meetings magazine, sought to determine whether attending…
FDA FDA Reorganizing Office of Prescription Drug Promotion Thomas Sullivan Mar 29, 2013 0 Janet Woodcock, Director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA) announced…
Uncategorized OIG Offers Compliance Tips for Healthcare Boards, Executives Thomas Sullivan Mar 28, 2013 0 Two of the most recent settlements involving pharmaceutical companies alleged to have engaged in off-label promotion, included…
FDA Court Upholds InterMune Executive Conviction on Misleading Speech Thomas Sullivan Mar 28, 2013 0 In December of last year, we reported on a landmark ruling from the United States Court of Appeals for the Second Circuit (New…
CME Resolving Conflicts of Interest in CME Thomas Sullivan Mar 27, 2013 0 With increased focus on transparency and reporting or monitoring conflicts of interest (COI), there is more and more pressure on…
Academic Organizations Medical Students Eating Lunches but Feeling Guilty Thomas Sullivan Mar 26, 2013 0 Eating lunches and feeling guilty is something we are supposed to do when we are older after we have gained some weight. But now…
Uncategorized Par Pharmaceuticals Settles Off-Label Case, Drops First Amendment Case Thomas Sullivan Mar 25, 2013 0 Earlier this month, New Jersey-based Par Pharmaceutical Companies Inc. (“Par”) pleaded guilty in federal court agreed to pay $45…